Evidence map›Paper›PMID 41021640›Full record

ArticlePLoS genetics2025

On the analysis of genetic association with long-read sequencing data.

Gengming He, Stephen W Scherer, Lisa J Strug

Abstract read
In one paragraph

Article in PLoS genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gengming HeBiostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-0971-8807
Stephen W SchererProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Lisa J StrugBiostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-0503-9740

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-read sequencing (LRS) technologies have enhanced the ability to resolve complex genomic architecture and determine the 'phase' relationships of genetic variants over long distances. Although genome-wide association studies (GWAS) identify individual variants associated with complex traits, they do not typically account for whether multiple associated signals at a locus may act in cis or trans, or whether they reflect allelic heterogeneity. As a result, effects that arise specifically from phase relationships may remain hidden in analyses using short-read and microarray data. While the advent of LRS has enabled accurate measurement of phase in population cohorts, statistical methods that leverage phase in genetic association analysis remain underdeveloped. Here, we introduce the Regression on Phase (RoP) method, which directly models cis and trans phase effects between variants under a regression framework. In simulations, RoP outperforms genotype interaction tests that detect phase effects indirectly, and distinguishes in-cis from in-trans phase effects. We implemented RoP at two cystic fibrosis (CF) modifier loci discovered by GWAS. At the chromosome 7q35 trypsinogen locus, RoP confirmed that two variants contributed independently (allelic heterogeneity). At the SLC6A14 locus on chromosome X, phase analysis uncovered a coordinated regulatory mechanism in which a promoter variant modulates lung phenotypes in individuals with CF when acting in cis with a lung-specific enhancer (E2765449/enhD). This coordinated regulation was confirmed in functional studies. These findings highlight the potential of leveraging phase information from LRS in genetic association studies. Analyzing phase effects with RoP can provide deeper insights into the complex genetic architectures underlying disease phenotypes, ultimately guiding more informed functional investigations and potentially revealing new therapeutic targets.

Indexed as

Cystic FibrosisGenome-Wide Association StudyChromosomes, Human, Pair 7Cystic Fibrosis Transmembrane Conductance RegulatorHumansModels, GeneticPolymorphism, Single NucleotideCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID41021640
PMCPMC12500163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.